Evidence map›Paper›PMID 40832440›Full record

ArticleACS sustainable chemistry & engineering2025

Engineering

Yoo-Sung Ko, Di Gu, Amy Lee, Dunya Al Marzooqi, Wenjun Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS sustainable chemistry & engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yoo-Sung KoDepartment of Chemical and Biomolecular Engineering, University of California Berkeley, Berkeley, California 94720, United States.
Di GuDepartment of Chemistry, University of California Berkeley, Berkeley, California 94720, United States.
Amy LeeDepartment of Chemistry, University of California Berkeley, Berkeley, California 94720, United States.
Dunya Al MarzooqiDepartment of Chemical and Biomolecular Engineering, University of California Berkeley, Berkeley, California 94720, United States.
Wenjun ZhangDepartment of Chemical and Biomolecular Engineering, University of California Berkeley, Berkeley, California 94720, United States.

Funding

Bioactive natural product discovery from human oral microbesR01DE032732 · NIDCR · UNIVERSITY OF CALIFORNIA BERKELEY · PI Wenjun Zhang · 2024 to 2026
$1.1M
Acquisition of a Cryoprobe and Related Accessories for a 600 MHz NMR Spectrometer to Support Health Research Activities at the University of California, BerkeleyS10OD024998 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI HARTWIG, JOHN F · 2018 to 2018
$265k
NIDCR NIH HHS R01 DE032732NIH HHS S10 OD024998
6 · The paper itself

Abstract

Salivabactin, a newly discovered hybrid polyketide/nonribosomal peptide (PK/NRP) antibiotic with a unique scaffold, exhibits potent activity against Gram-positive pathogens such as

Indexed as

AntibioticEscherichia coliMetabolic EngineeringPKS/NRPSSalivabactin

Identifiers

PMID40832440
PMCPMC12360414

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.